COAGULATION FACTOR IX RECOMBINANT HUMAN for Haemophilia: Side Effects & Safety Data
Boost Your Natural Energy & Metabolism
Mitolyn — 6 exotic plants to unlock your body's fat-burning power. 90-day guarantee.
There are 25 adverse event reports in the FDA FAERS database where COAGULATION FACTOR IX RECOMBINANT HUMAN was used for Haemophilia.
Most Reported Side Effects for COAGULATION FACTOR IX RECOMBINANT HUMAN
| Side Effect | Reports | % | Deaths | Hosp. |
|---|---|---|---|---|
| Haemarthrosis | 318 | 29.8% | 2 | 48 |
| Haemorrhage | 261 | 24.5% | 1 | 34 |
| No adverse event | 97 | 9.1% | 0 | 4 |
| Traumatic haemorrhage | 62 | 5.8% | 1 | 11 |
| Fall | 61 | 5.7% | 0 | 14 |
| Drug ineffective | 60 | 5.6% | 1 | 6 |
| Muscle haemorrhage | 54 | 5.1% | 0 | 12 |
| Arthralgia | 52 | 4.9% | 0 | 6 |
| Contusion | 52 | 4.9% | 0 | 5 |
| Device issue | 43 | 4.0% | 0 | 0 |
| Product preparation issue | 39 | 3.7% | 0 | 0 |
| Head injury | 33 | 3.1% | 0 | 5 |
| Joint swelling | 32 | 3.0% | 0 | 6 |
| Pain | 31 | 2.9% | 1 | 10 |
| Epistaxis | 29 | 2.7% | 0 | 3 |
Other Indications for COAGULATION FACTOR IX RECOMBINANT HUMAN
Factor ix deficiency (758)
Prophylaxis (239)
Product used for unknown indication (88)
Haemorrhage (65)
Haemorrhage prophylaxis (52)
Haemarthrosis (26)
Factor viii deficiency (24)
Haemostasis (22)
Haemorrhagic diathesis (8)
Traumatic haemorrhage (6)
Other Drugs Used for Haemophilia
ANTIHEMOPHILIC FACTOR, HUMAN RECOMBINANT (796)
EMICIZUMAB-KXWH (402)
ANTI-INHIBITOR COAGULANT COMPLEX (335)
--BLOOD-COAGULATION FACTOR VIII FUSION PROTEIN WITH IMMUNOGLOBULIN G1 , ,-BIS WITH IMMUNOGLOBULIN G1 (235)
EFTRENONACOG ALFA (148)
COAGULATION FACTOR IX RECOMBINANT HUMAN\ISOPROPYL ALCOHOL (75)
EMICIZUMAB (47)
COAGULATION FACTOR VIIA RECOMBINANT HUMAN (44)
ANTIHEMOPHILIC FACTOR, HUMAN RECOMBINANT RESIDUES 743-1636 DELETED (43)
ANTIHEMOPHILIC FACTOR, PEGYLATED HUMAN SEQUENCE RECOMBINANT (35)